For many patients, the answer will be yes the medication is bioequivalent, the injection device is comparable, and the cost savings are real
Third, although protective effects were observed in preclinical models, their applicability to human OA remains uncertain, and well-designed clinical trials are necessary to validate these findings
Toward the autism motor signature: gesture patterns during smart tablet gameplay identify children with autism
Exploring the therapeutic potential of bioactive compounds from plant sources
In the brain, GLP-1 may influence inflammation in the brain, which may protect against degenerative conditions like dementia and Alzheimers disease
More research is needed to determine whether this is the case